HIGHLIGHTS
- who: Ulrike Baschant from the University of Bristol, United Kingdom have published the Article: Editorial: Glucocorticoid and bone: Friend or foe, in the Journal: (JOURNAL)
- what: The study shows a gradual overall BMD loss over 2 years at the lumbar spine. The study shows that trabecular bone score decreased significantly in 33% of patients treated with high dose intravenous methylprednisolone.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.